Related by context. Frequent words. (Click for all words.) 60 ALLHAT 60 phase IIa 59 Cardiovascular Risk 59 QNEXA 57 Pivotal Phase III 57 ocrelizumab 57 phase IIb 56 6R BH4 56 taranabant 56 placebo controlled clinical trials 56 Phase Ib clinical 56 NLX P# 56 double blinded placebo 56 TRITON TIMI 56 Empatic 55 muraglitazar 55 GSK# [001] 55 placebo controlled Phase 55 Pivotal Trial 55 active comparator 55 Diabetologia 55 Pirfenidone 55 placebo controlled clinical 55 lixisenatide 54 secondary efficacy endpoints 54 SPIRIT III 54 irbesartan 54 randomized Phase III 54 darapladib 54 Phase III Clinical Trial 54 placebo controlled randomized 54 blinded placebo controlled 54 tolvaptan 54 Pivotal Phase 53 ataluren 53 glycated hemoglobin 53 placebo controlled trials 53 elotuzumab 53 Naproxcinod 53 Phase 1b clinical 53 atherothrombosis 53 Phase 2a clinical 53 Patient Enrollment 53 Duloxetine 53 JANUVIA 53 liraglutide 53 placebo controlled studies 53 omecamtiv mecarbil 53 uncontrolled hypertension 53 Phase III Trial 52 DSMB 52 Completes Enrollment 52 Diamyd ® 52 JAMA. 52 Clinical Trial Results 52 Keppra ® 52 aclidinium 52 Phase Ib 52 BCX# 52 pertuzumab 52 telmisartan 52 Overactive Bladder 52 Cholesterol Drug 52 Phase 1b trial 52 Phase 2a trial 52 multicenter clinical 52 Co MRK 52 subgroup analyzes 52 randomized controlled clinical 52 ISIS # 52 Arch Neurol 51 N Engl J 51 darusentan 51 Phase IIa clinical trials 51 perindopril 51 dapagliflozin 51 ROTATEQ 51 tanespimycin 51 fingolimod 51 randomized controlled clinical trials 51 glitazones 51 MIRCERA 51 Secondary endpoints 51 Postmenopausal Women 51 PRECiSE 51 alvimopan 51 IIa clinical trial 51 Dyslipidemia 51 Board DSMB 51 ADHF 51 Atacand 51 prospective observational 51 Rosuvastatin 51 SABCS 51 fasting glucose levels 51 PRX # 51 lipid profiles 51 prospective multicenter 51 multicenter randomized double 51 valsartan 51 multicentre